Advanced search
1 file | 10.34 MB

Keeping mutant plasma gelsolin safe from harm: gelsolin nanobodies act as a chaperone against pathological proteolysis

(2015)
Author
Promoter
(UGent)
Organization

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 10.34 MB

Citation

Please use this url to cite or link to this publication:

Chicago
Van Overbeke, Wouter. 2015. “Keeping Mutant Plasma Gelsolin Safe from Harm: Gelsolin Nanobodies Act as a Chaperone Against Pathological Proteolysis”. Ghent, Belgium: Ghent University. Faculty of Medicine and Health Sciences.
APA
Van Overbeke, W. (2015). Keeping mutant plasma gelsolin safe from harm: gelsolin nanobodies act as a chaperone against pathological proteolysis. Ghent University. Faculty of Medicine and Health Sciences, Ghent, Belgium.
Vancouver
1.
Van Overbeke W. Keeping mutant plasma gelsolin safe from harm: gelsolin nanobodies act as a chaperone against pathological proteolysis. [Ghent, Belgium]: Ghent University. Faculty of Medicine and Health Sciences; 2015.
MLA
Van Overbeke, Wouter. “Keeping Mutant Plasma Gelsolin Safe from Harm: Gelsolin Nanobodies Act as a Chaperone Against Pathological Proteolysis.” 2015 : n. pag. Print.
@phdthesis{5781860,
  author       = {Van Overbeke, Wouter},
  language     = {eng},
  pages        = {IV, 143},
  publisher    = {Ghent University. Faculty of Medicine and Health Sciences},
  school       = {Ghent University},
  title        = {Keeping mutant plasma gelsolin safe from harm: gelsolin nanobodies act as a chaperone against pathological proteolysis},
  year         = {2015},
}